Re: Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate Kallikreins measured at age 44 to 50 years - Lilja H, Ulmert D, Bjork T, Becker C, Serio AM, Nilsson JA, Abrahamsson PA, Vickers AJ, Berglund G

Autor: Bangma, C.H.

Publikováno v: European Urology, 51(5), 1439-1440. Elsevier

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::bf48b674fef055aa4c687b038de12574
https://pure.eur.nl/en/publications/aa6b9321-7d0b-4633-8c4d-a80e81c797eb

A non-invasive 25-Gene PLNM-Score urine test for detection of prostate cancer pelvic lymph node metastasis.

Autor: Guo J; Department of Urology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University), Shenzhen, China.; Shenzhen Clinical Research Centre for Geriatrics, Shenzhen People's Hospital, Shenzhen, China.; Shenzhen Urology Minimally Invasive Engineering Center, Shenzhen, China.; Shenzhen Public Service Platform on Tumor Precision Medicine and Molecular Diagnosis, Clinical Medicine Research Centre, Shenzhen, China.; The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen, China., Gu L; Department of Urology, The Third Medical Centre, Chinese PLA General Hospital, Beijing, China., Johnson H; Olympia Diagnostics, Inc., Sunnyvale, CA, USA., Gu D; Department of Urology, The First affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Lu Z; The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Luo B; The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Yuan Q; Department of Urology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University), Shenzhen, China.; The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen, China., Zhang X; Department of Bio-diagnosis, Institute of Basic Medical Sciences, Beijing, China., Xia T; Department of Urology, Foshan First People's Hospital, Foshan, China., Zeng Q; Department of Urology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China., Wu AHB; Clinical Laboratories, San Francisco General Hospital, San Francisco, CA, USA., Johnson A; Kinetic Reality, Santa Clara, USA., Dizeyi N; Department of Translational Medicine, Lund University, Clinical Research Centre, Malmö, Sweden., Abrahamsson PA; Department of Translational Medicine, Lund University, Clinical Research Centre, Malmö, Sweden., Zhang H; Department of Bio-diagnosis, Institute of Basic Medical Sciences, Beijing, China., Chen L; Department of Urology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China., Xiao K; Department of Urology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University), Shenzhen, China.; The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen, China., Zou C; Department of Urology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University), Shenzhen, China. zou.chang@szhospital.com.; Shenzhen Urology Minimally Invasive Engineering Center, Shenzhen, China. zou.chang@szhospital.com.; Shenzhen Public Service Platform on Tumor Precision Medicine and Molecular Diagnosis, Clinical Medicine Research Centre, Shenzhen, China. zou.chang@szhospital.com.; The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen, China. zou.chang@szhospital.com.; Key Laboratory of Medical Electrophysiology of Education Ministry, School of Pharmacy, Southwest Medical University, Luzhou, China. zou.chang@szhospital.com., Persson JL; Department of Molecular Biology, Umeå University, Umeå, Sweden. jenny.persson@umu.se.; Department of Biomedical Sciences, Malmö University, Malmö, Sweden. jenny.persson@umu.se.

Publikováno v: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2024 Feb 02. Date of Electronic Publication: 2024 Feb 02.

Non-invasive Urine Test for Molecular Classification of Clinical Significance in Newly Diagnosed Prostate Cancer Patients.

Autor: Guo J; Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.; Shenzhen Urology Minimally Invasive Engineering Center, Shenzhen, China.; Shenzhen Public Service Platform on Tumor Precision Medicine and Molecular Diagnosis, Clinical Medicine Research Centre, Shenzhen, China., Zhang X; Department of Bio-diagnosis, Institute of Basic Medical Sciences, Beijing, China., Xia T; Department of Urology, Foshan First People's Hospital, Foshan, China., Johnson H; Olympia Diagnostics, Inc., Sunnyvale, CA, United States., Feng X; Department of Bio-diagnosis, Institute of Basic Medical Sciences, Beijing, China., Simoulis A; Department of Clinical Pathology and Cytology, Skåne University Hospital, Malmö, Sweden., Wu AHB; Clinical Laboratories, San Francisco General Hospital, San Francisco, CA, United States., Li F; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Tan W; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Johnson A; Kinetic Reality, Santa Clara, CA, United States., Dizeyi N; Department of Translational Medicine, Clinical Research Centre, Lund University, Malmö, Sweden., Abrahamsson PA; Department of Translational Medicine, Clinical Research Centre, Lund University, Malmö, Sweden., Kenner L; Department of Experimental Pathology, Medical University Vienna & Unit of Laboratory Animal Pathology, University of Veterinary Medicine, Vienna, Austria., Xiao K; Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.; Shenzhen Urology Minimally Invasive Engineering Center, Shenzhen, China.; Shenzhen Public Service Platform on Tumor Precision Medicine and Molecular Diagnosis, Clinical Medicine Research Centre, Shenzhen, China., Zhang H; Department of Bio-diagnosis, Institute of Basic Medical Sciences, Beijing, China., Chen L; Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Zou C; Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.; Shenzhen Urology Minimally Invasive Engineering Center, Shenzhen, China.; Shenzhen Public Service Platform on Tumor Precision Medicine and Molecular Diagnosis, Clinical Medicine Research Centre, Shenzhen, China.; Key Laboratory of Medical Electrophysiology of Education Ministry, School of Pharmacy, Southwest Medical University, Luzhou, China., Persson JL; Department of Molecular Biology, Umeå University, Umeå, Sweden.; Department of Biomedical Sciences, Malmö University, Malmö, Sweden.; Division of Experimental Cancer Research, Department of Translational Medicine, Lund University, Malmö, Sweden.

Publikováno v: Frontiers in medicine [Front Med (Lausanne)] 2021 Sep 14; Vol. 8, pp. 721554. Date of Electronic Publication: 2021 Sep 14 (Print Publication: 2021).

A 23-Gene Classifier urine test for prostate cancer prognosis.

Autor: Guo J; Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen Urology Minimally Invasive Engineering Centre, Shenzhen, China.; Shenzhen Public Service Platform on Tumor Precision Medicine and Molecular Diagnosis, Clinical Medical Research Centre, Shenzhen, China., Johnson H; Olympia Diagnostics, Inc., Sunnyvale, California., Zhang X; Department of Bio-Diagnosis, Institute of Basic Medical Sciences, Beijing, China., Feng X; Department of Bio-Diagnosis, Institute of Basic Medical Sciences, Beijing, China., Zhang H; Department of Bio-Diagnosis, Institute of Basic Medical Sciences, Beijing, China., Simoulis A; Department of Clinical Pathology and Cytology, Skåne University Hospital, Malmö, Sweden., Wu AH; Clinical Laboratories, San Francisco General Hospital, San Francisco, California., Xia T; Department of Urology, Foshan First People's Hospital, Foshan, China., Li F; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Tan W; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Johnson A; Kinetic Reality, Santa Clara, California., Dizeyi N; Department of Translational Medicine, Lund University, Clinical Research Centre, Malmö, Sweden., Abrahamsson PA; Department of Translational Medicine, Lund University, Clinical Research Centre, Malmö, Sweden., Kenner L; Department of Experimental Pathology, Medical University Vienna & Unit of Laboratory Animal Pathology, University of Veterinary Medicine, Vienna, Austria., Chen L; Department of Urology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China., Zhong W; Department of Urology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China., Xiao K; Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen Urology Minimally Invasive Engineering Centre, Shenzhen, China.; Shenzhen Public Service Platform on Tumor Precision Medicine and Molecular Diagnosis, Clinical Medical Research Centre, Shenzhen, China., Persson JL; Department of Molecular Biology, Umeå University, Umeå, Sweden.; Department of Biomedical Sciences, Malmö University, Malmö, Sweden.; Division of Experimental Cancer Research, Department of Translational Medicine, Lund University, Malmö, Sweden., Zou C; Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen Urology Minimally Invasive Engineering Centre, Shenzhen, China.; Shenzhen Public Service Platform on Tumor Precision Medicine and Molecular Diagnosis, Clinical Medical Research Centre, Shenzhen, China.

Publikováno v: Clinical and translational medicine [Clin Transl Med] 2021 Mar; Vol. 11 (3), pp. e340.

Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-up.

Autor: Johnson H; Olympia Diagnostics, Inc., Sunnyvale, CA, USA., Guo J; Department of Urology, The Second Clinical Medical College of Jinan University, Shenzhen People's Hospital, Shenzhen Urology Minimally Invasive Engineering Centre, Shenzhen, China.; Shenzhen Public Service Platform on Tumor Precision Medicine and Molecular Diagnosis, Clinical Medical Research Centre, The Second Clinical College of Jinan University, Shenzhen People's Hospital, Shenzhen, China., Zhang X; Department of Bio-diagnosis, Institute of Basic Medical Sciences, Beijing, China., Zhang H; Department of Bio-diagnosis, Institute of Basic Medical Sciences, Beijing, China., Simoulis A; Department of Clinical Pathology and Cytology, Skåne University Hospital, Malmö, Sweden., Wu AHB; Clinical Laboratories, San Francisco General Hospital, San Francisco, CA, USA., Xia T; Department of Urology, Foshan First People's Hospital, Foshan, China., Li F; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Tan W; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Johnson A; Kinetic Reality, Santa Clara, CA, USA., Dizeyi N; Department of Translational Medicine, Lund University, Clinical Research Centre, Malmö, Sweden., Abrahamsson PA; Department of Translational Medicine, Lund University, Clinical Research Centre, Malmö, Sweden., Kenner L; Department of Experimental Pathology, Medical University Vienna & Unit of Laboratory Animal Pathology, University of Veterinary Medicine, Vienna, Austria., Feng X; Department of Bio-diagnosis, Institute of Basic Medical Sciences, Beijing, China., Zou C; Shenzhen Public Service Platform on Tumor Precision Medicine and Molecular Diagnosis, Clinical Medical Research Centre, The Second Clinical College of Jinan University, Shenzhen People's Hospital, Shenzhen, China., Xiao K; Department of Urology, The Second Clinical Medical College of Jinan University, Shenzhen People's Hospital, Shenzhen Urology Minimally Invasive Engineering Centre, Shenzhen, China.; Shenzhen Public Service Platform on Tumor Precision Medicine and Molecular Diagnosis, Clinical Medical Research Centre, The Second Clinical College of Jinan University, Shenzhen People's Hospital, Shenzhen, China., Persson JL; Department of Molecular Biology, Umeå University, 901 87, Umeå, Sweden. jenny.persson@umu.se.; Division of Experimental Cancer Research, Department of Translational Medicine, Lund University, 205 02, Malmö, Sweden. jenny.persson@umu.se.; Department of Biomedical Sciences, Malmö University, Malmö, Sweden. jenny.persson@umu.se., Chen L; Department of Urology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, Guangdong, China. chenlwu@mail.sysu.edu.cn.

Publikováno v: BMC medicine [BMC Med] 2020 Dec 01; Vol. 18 (1), pp. 376. Date of Electronic Publication: 2020 Dec 01.